In DLBCL NOS in the lymph node (n = 78), mutations in PIM1 (n = 22, 28.2%), BTG1 (n = 22, 28.2%), and TP53 (n = 20, 25.6%) were the most common. This evidence concerns the gene PIM1 and diffuse large B-cell lymphoma.